Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
- 20 November 1980
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 303 (21) , 1195-1198
- https://doi.org/10.1056/nejm198011203032102
Abstract
We interviewed 327 women who had been 50 to 74 years of age when treated for fracture of the hip or lower forearm, to determine their use (or lack of use) of estrogen preparations. Their responses were compared with those in a random sample of 567 women who were of similar age and from the same region. The risk of fracture was 50 to 60 per cent lower in women who had used these drugs for six years or longer than in women who had not used them (95 per cent confidence interval of relative risk, 0.3 to 0.6); those using them for shorter periods received less benefit, if any. A decreased risk of fracture was clearly evident only in women still taking estrogens and evident at either common daily dose (0.625 and 1.25 mg).This publication has 8 references indexed in Scilit:
- POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control StudyThe Lancet, 1979
- Endometrial cancer in relation to patterns of menopausal estrogen useJAMA, 1979
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978
- Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal WomenAnnals of Internal Medicine, 1977
- Prospective trial of oestrogen and calcium in postmenopausal women.BMJ, 1977
- ESTROGENS AND POSTMENOPAUSAL OSTEOPOROSISClinical Obstetrics and Gynecology, 1976
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976
- ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIESAmerican Journal of Epidemiology, 1976